Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 50Lymphoma, Non-Hodgkin 45Lymphoma 34Lymphoma, Mantle-Cell 30Lymphoma, Follicular 26Multiple Myeloma 23Hodgkin Disease 21Lymphoma, Large B-Cell, Diffuse 18Recurrence 13Lymphoma, B-Cell, Marginal Zone 12Leukemia 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Neoplasms 6Lymphoma, T-Cell 5Waldenstrom Macroglobulinemia 4Lymphoma, Large-Cell, Anaplastic 4Lymphoma, B-Cell 4Leukemia, Myeloid, Acute 4Leukemia, B-Cell 4Breast Neoplasms 4Small Cell Lung Carcinoma 3Sezary Syndrome 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Neoplasms, Plasma Cell 3Myelodysplastic Syndromes 3Mycosis Fungoides 3Lymphoma, T-Cell, Peripheral 3Lymphoma, T-Cell, Cutaneous 3Lymphoma, Extranodal NK-T-Cell 3Immunoblastic Lymphadenopathy 3

Interventions

toripalimab 6Injections 4tislelizumab 3sintilimab 3pembrolizumab 3cediranib 3glumetinib 2apatinib 2PM 01183 2Midazolam 2Irinotecan 2Gemcitabine 2Drug Therapy 2Digoxin 2Bupropion 2talazoparib 1spartalizumab 1sonidegib 1sitravatinib 1serabelisib 1sapanisertib 1rucaparib 1repaglinide 1penpulimab 1palbociclib 1lenvatinib 1fluzoparib 1erdafitinib 1entrectinib 1dactolisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Advanced Solid Tumor × Bendamustine Hydrochloride × Clear all
NCT03604679 2021-04-27

SyB C-0501(Oral Bendamustine) in Patients With Advanced Solid Tumors

SymBio Pharmaceuticals

Phase 1 Completed
18 enrolled
Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡